Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CONCORD BIOTECH Gains 6%; BSE HEALTHCARE Index Up 0.4%
Thu, 27 Jun 16:3

CONCORD BIOTECH Gains 6%; BSE HEALTHCARE Index Up 0.4%Image source: Sakorn BernardaSv/www.istockphoto.com

CONCORD BIOTECH share price has zoomed 6% and is presently trading at Rs 1,580.0.

Meanwhile, the BSE HEALTHCARE index is at 36,831.0 (up 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 7.3%) and SUVEN PHARMACEUTICALS (up 6.5%).

POLY MEDICURE (down 3.6%) and HIKAL CHEMIC (down 3.1%) are among the top losers today.

Over the last one year, CONCORD BIOTECH has moved up from Rs 0.0 to Rs 1,580.0, registering a gain of Rs 1,580.0 .

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,831.0, registering a gain of 45.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 88.9%), Glenmark Pharma (up 88.9%) and GSK Pharma (up 87.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,245.0 (up 0.7%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 5.3%) and NTPC (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.

In the meantime, NSE Nifty is at 24,036.1 (up 0.7%). Ultratech Cement and LTIMINDTREE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 79,245.0, registering a gain of 16,275.0 points (up 25.8%).

CONCORD BIOTECH Financial Update...

CONCORD BIOTECH net profit fell {profitpercent} YoY to Rs 972 million for the quarter ended March 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 3,190 million during the period as against Rs {salesnumberprev} million in {quarterprev}.

For the year ended March 2024, CONCORD BIOTECH reported 28.3% increase in net profit to Rs 3,081 million compared to net profit of Rs 2,401 million during FY23. Revenue of the company grew 19.2% to Rs 10,169 million during FY24.

The current Price to earnings ratio of CONCORD BIOTECH, based on rolling 12 month earnings, stands at 54.2.


Equitymaster requests your view! Post a comment on "CONCORD BIOTECH Gains 6%; BSE HEALTHCARE Index Up 0.4%". Click here!